Netherlands· NL-2976efa44b8b

Levocarnitine ERC drank 1 g/10 ml, drank

A levocarnitine product containing levocarnitine, registered in Netherlands by Euro Registratie Collectief B.V.. The same ATC class is registered in 11 of our 19 countries.

ATC A16AA01

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about levocarnitineAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Levocarnitine is registered in 11 of 19 countries.

Countries holding a registration under ATC A16AA01 (levocarnitine), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
6 of them publish a price we can compare per daily dose

Search levocarnitine products by name

Levocarnitine · ATC A16AA01

11 / 19 countries

Canada
Finlandprice
Franceprice
Germany
Italyprice
Japan
Netherlands
Norwayprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of levocarnitine costs, country by country.

Normalised to the WHO defined daily dose (2 g), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Levocarnitine · price per daily dose (2 g)

USD · FX 28 Sept 2026

CH Switzerland$9.46

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: LEVOCARNITINE
Manufacturer: Euro Registratie Collectief B.V.
Country: Netherlands (NL)
ATC code: A16AA01
ATC class: Levocarnitine
Defined daily dose: 2 g, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
102436//11193

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

81 interactions on record for levocarnitine.

Graded by severity as the source publishes them — 2 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check levocarnitine against other medicines How interaction checks work

Levocarnitine · interactions on record

81 records

2 moderate
79 info

Most severe, free to view

DicoumarolB01AA01moderate
WarfarinB01AA03moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Levocarnitine in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All levocarnitine products

Authorised across Europe · EMA

The same active substance is authorised in 11 EEA countries. Names it is sold under:

Austria · L-Carnitin Fresenius, Nefrocarnit
Cyprus · Frutenor, Intelecta
Germany · Biocarn, L-Carn
Spain · Carnicor
France · Levocarnil, Levocarnitine Uni-Pharma
United Kingdom (Northern Ireland) · Levocarnitine Aspire Pharma, Levocarnitine Neon Healthcare
Greece · Aminocer, Carniben
Italy · Carnitene, Carnitene Alfasigma
Luxembourg · Nefrocarnit®
Portugal · Disocor
Romania · Carnil

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/fbedb748-a151-4151-8581-8a62e40aafd7
GET /v1/drugs/fbedb748-a151-4151-8581-8a62e40aafd7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Drank",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h11193_smpc.pdf",
  "strength": null,
  "atc_label": "Levocarnitine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg102436",
  "excipients": [
    "APPELZUUR, (DL)(+-)(E 296)",
    "NATRIUMMETHYLPARAHYDROXYBENZOAAT (E 219)",
    "NATRIUMPROPYLPARAHYDROXYBENZOAAT",
    "SACCHAROIDE NATRIUM X-WATER (E 954)",
    "WATER, GEZUIVERD"
  ],
  "substances": [
    "LEVOCARNITINE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h102436.pdf",
  "authorised_at": "2008/07/21",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "102436//11193",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about levocarnitine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console